Skip to main content
. 2023 Feb 28;14:1082720. doi: 10.3389/fendo.2023.1082720

Figure 2.

Figure 2

Unadjusted Kaplan−Meier hazard curves for risk of diabetic peripheral neuropathy. Figure (A) shows the curves of diabetic peripheral neuropathy for the metformin and non-metformin groups; Figure (B) shows the incidence curves for average daily dose groups.